The latest news from Sutura
Stay up-to-date with Sutura Therapeutics' latest innovations and advancements by visiting our newsroom regularly.
PeptiGos, a Next Generation CPP Platform
After 40 years, cell-penetrating peptides are finally realising their potential - Dr Wouter Eilers of Sutura explains how Sutura’s PeptiGo platform aims to perfect delivery.
Sutura Therapeutics Completes Investment Round
BREAKING: Sutura Therapeutics, a private biopharmaceutical company developing peptide-based biomolecular medicinal products, completes seed investment round.